21 CFR 556.570

§ 556.570 Ractopamine.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 556.570, § 556.570 Ractopamine, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87807
Permanent ID: ys:prov:87807@1
SHA-256: 1c28ddebbaf1b592459e65a56bb30edc5e362ea213415e44a8740f133a869ad7

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Acceptable daily intake (ADI). The ADI for total residue of ractopamine hydrochloride is 1.25 µg/kg of body weight per day. (b) Tolerances. The tolerances for ractopamine (marker residue) are: (1) Cattle. (i) Liver (target tissue): 0.09 ppm. (ii) Muscle: 0.03 ppm. (2) Swine. (i) Liver (target tissue): 0.15 ppm. (ii) Muscle: 0.05 ppm. (3) Turkeys. (i) Liver (target tissue): 0.45 ppm. (ii) Muscle: 0.1 ppm. (c) Related conditions of use. See § 558.500 of this chapter.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.